Year: 2006
Type: article
Abstract: In contrast to serial injections of recombinant protein, prolonged systemic delivery of proteins derived through in vivo gene transfer may ultimately provide a favorable alternative for long-term therapy of chronic inflammatory diseases such as the predominant use of interferon-beta (IFNβ) in the treatment of multiple sclerosis (MS). In the current study we compared the therapeutic efficacies of electroporation (EP) mediated intramuscular IFNβ gene transfer with repeated alternate day injections of recombinant IFNβ after onset of experimental autoimmune encephalomyelitis (EAE), an animal model widely used in MS research.
Source: Molecular Therapy
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W2006068657